Robert W. Duggan

Robert W. Duggan

Chair of the BoardatSummit Therapeutics· In proxies 2022–2025

Pay in FY2025+9% from the year before · Summit Therapeutics stock -2.0% the same year

Robert W. Duggan was paid $172.4K in FY2025 (Dec), up 9%. Summit Therapeutics stock fell 2.0% that year.

Pay$100 in the stock at the end of FY21 → $650
Pay is from the Summary Compensation Table of each Summit Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Pulse BiosciencesPublic company · 3 yr
    • Chair of the Board2023 – Present · 3 yrNo stock prices for these years
  2. Summit TherapeuticsPublic company · 4 yr
    • Co-Chief Executive Officer and Chairman2022 – Present · 4 yrStock in role +484%
  3. Pulse Biosciences, Inc.Public company · 9 yr
    • Director2017 – Present · 9 yrNo stock prices for these years
  4. Blazon CorporationPublic company
    • Director? – PresentNo stock prices for these years
  5. DeepsightPublic company
    • Director? – PresentNo stock prices for these years
  6. Duggan Investments ResearchPublic company
    • Director? – PresentNo stock prices for these years
  7. Genuine First Aid InternationalPublic company
    • Director? – PresentNo stock prices for these years
  8. Medical Distribution IndustriesPublic company
    • Director? – PresentNo stock prices for these years
  9. Pharmacyclics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  10. Intuitive Surgical Inc.Public company · 8 yr
    • Director2003 – 2011 · 8 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • Summit TherapeuticsChair · 6 yr on the boardNot independent—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?